Britain's far right is booming on Elon Musk's Twitter (www.euronews.com)
Wimbledon to trial 5G headsets for visually impaired tennis fans (www.euronews.com)
Polish demand for recognition of WWII massacres sparks row with Kyiv (www.euronews.com)
Dutch government reportedly collapses after migration deal fails (www.euronews.com)
France: A Nation Takes Stock After Teen's Death (www.spiegel.de)
U.S. to send widely banned cluster munitions to Ukraine (www.axios.com)
The narcissism that blinds Israelis to Jenin’s oppression (www.972mag.com)
Skin cancer cases reach record high in UK with sharp rise among older adults (www.theguardian.com)
‘Terrible mistake’: human rights groups decry sending cluster bombs to Ukraine (www.theguardian.com)
Brazil: Amazon deforestation drops 34% in first six months under Lula (www.theguardian.com)
Ben-Gvir calls bereaved Palestinian mother 'terrorist' (www.newarab.com)
US must urgently treat men tortured at Guantánamo, UN investigator says (www.theguardian.com)
Why did Stanford students host a group of neo-Nazis? (forward.com)
Latin American countries refuse to see Zelenskyy at summit with EU (www.pravda.com.ua)
The first drug that slows Alzheimer's has finally received FDA approval (www.engadget.com)
Japanese drugmaker Eisai and US-based Biogen have been working together on advancing research in the space of Alzheimer’s for nearly a decade. Finally, the FDA, granted the fruits of that labor, Leqembi, its blessing for intravenous use. This marks the first approved treatment that can slow the progression of Alzheimer’s.